Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
The aim of this study was to evaluate the risk of malignancy (RoM) in category III thyroid nodules of the Bethesda system in patients with and without Hashimoto thyroiditis (HT) and to analyze whether obtaining category III with a repeat FNA (rFNA) increases RoM. The study included 563 HT and 1250 n...
Main Authors: | Klencki, M. (Author), Popowicz, B. (Author), Słowińska-Klencka, D. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Thyroid Bethesda Category AUS/FLUS in Our Microscopes: Three-Year-Experience and Cyto-Histological Correlation
by: Roope Huhtamella, et al.
Published: (2019-10-01) -
Evaluation of thyroid nodules classified as Bethesda category III on FNAC
by: Shiwani Garg, et al.
Published: (2017-01-01) -
Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
by: Adnan Zahid, et al.
Published: (2021-03-01) -
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
by: Shilpa Thakur, et al.
Published: (2019-09-01) -
Diagnostic Value of Six Thyroid Imaging Reporting and Data Systems (TIRADS) in Cytologically Equivocal Thyroid Nodules
by: Dorota Słowińska-Klencka, et al.
Published: (2020-07-01)